Business

Medincell to Present at the H.C. Wainwright 27th Global Investment Conference and Participate in the Morgan Stanley 23rd Global Healthcare Conference

MONTPELLIER, France, September 05, 2025--Regulatory News: Medincell (Paris:MEDCL):

articleMedincell SaSeptember 5, 20254/company/medincell-sa-1/news/medincell-to-present-at-the-hc-wainwright-27th-global-investment-conference-and-participate-in-the-morgan-stanley-23rd-global-healthcare-conference-1
Medincell to Present at the H.C. Wainwright 27th Global Investment Conference and Participate in the Morgan Stanley 23rd Global Healthcare Conference

About this update from Medincell Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1772,"height":295,"url":"https://media.zenfs.com/en/business-wire.com/537d807b569d09b6ab204ca4c0427cf1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.dqyox7ykoB6cACAvmevmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/537d807b569d09b6ab204ca4c0427cf1","width":960,"height":160},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/7XnYqlBoKBKNt62uPyYnbw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/537d807b569d09b6ab204ca4c0427cf1","width":1200,"height":200}},"lazy":false},{"type":"text","content":"MONTPELLIER, France, September 05, 2025--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"Medincell (Paris:MEDCL):","length":24,"tagName":"p"},{"type":"text","content":"Christophe Douat, Chief Executive Officer, will participate along with Dr Grace Kim, Chief Strategy Officer, U.S. Finance, in the following September New York conferences:","length":171,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"H.C. Wainright 27th Annual Global Investment Conference, September 8 - 10, 2025","length":79,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Presentation on September 10 at 12:00pm ET","length":42,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Live webcast and replay: https://journey.ct.events/view/d1fb9eda-ba64-4f78-a4a4-062934bcd890","length":92,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":134,"olType":false}]}],"tagName":"ul","bulletedList":true,"length":213,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Morgan Stanley 23rd Annual Global Healthcare Conference, September 8 - 10, 2025","length":79,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":79,"olType":false},{"type":"text","content":"Meetings may be requested via direct contact with Medincell or via banking representatives.","length":91,"tagName":"p"},{"type":"text","content":"About Medincell","length":15,"tagName":"p"},{"type":"text","content":"Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting ...

More updates from Medincell Sa

MedincellChief Strategy Officerforward-looking statementsThe CompanyGrace KimChief Executive Officer